<VariationArchive RecordType="classified" VariationID="17196" VariationName="NM_000393.5(COL5A2):c.1924-2_1928del" VariationType="Deletion" Accession="VCV000017196" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-11" DateCreated="2018-04-09" MostRecentSubmission="2018-04-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32235" VariationID="17196">
      <GeneList>
        <Gene Symbol="COL5A2" FullName="collagen type V alpha 2 chain" GeneID="1290" HGNC_ID="HGNC:2210" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="189031898" stop="189441111" display_start="189031898" display_stop="189441111" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="189896640" stop="190044604" display_start="189896640" display_stop="190044604" Strand="-" />
          </Location>
          <OMIM>120190</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000393.5(COL5A2):c.1924-2_1928del</Name>
      <CanonicalSPDI>NC_000002.12:189062913:GCTCCCT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="189062914" stop="189062920" display_start="189062914" display_stop="189062920" variantLength="7" positionVCF="189062913" referenceAlleleVCF="AGCTCCCT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="189927640" stop="189927646" display_start="189927640" display_stop="189927646" variantLength="7" positionVCF="189927639" referenceAlleleVCF="AGCTCCCT" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.189927640_189927646del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.189927640_189927646del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.189062914_189062920del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.189062914_189062920del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011799.3" sequenceAccession="NG_011799" sequenceVersion="3" change="g.167382_167388del">
            <Expression>NG_011799.3:g.167382_167388del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000393.5" sequenceAccession="NM_000393" sequenceVersion="5" change="c.1924-2_1928del" MANESelect="true">
            <Expression>NM_000393.5:c.1924-2_1928del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_738" sequenceAccession="LRG_738">
            <Expression>LRG_738:g.167382_167388del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_738t1" sequenceAccession="LRG_738t1">
            <Expression>LRG_738t1:c.1924-2_1928del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA281078" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="120190.0001" DB="OMIM" />
        <XRef Type="rs" ID="786205103" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9425231 Fig. 2a to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000393.5(COL5A2):c.1924-2_1928del AND Ehlers-Danlos syndrome, classic type" Accession="RCV000018736" Version="32">
        <ClassifiedConditionList TraitSetID="10583">
          <ClassifiedCondition DB="MedGen" ID="C4225429">Ehlers-Danlos syndrome, classic type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1998-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-04-09" MostRecentSubmission="2018-04-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9425231</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10583" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5006" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome, classic type</ElementValue>
                <XRef ID="MONDO:0007522" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">cEDS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2088" />
                <XRef ID="2088" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses.</Attribute>
                <XRef ID="NBK1244" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301422</ID>
                <ID Source="BookShelf">NBK1244</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987428</ID>
              </Citation>
              <XRef ID="287" DB="Orphanet" />
              <XRef ID="C4225429" DB="MedGen" />
              <XRef ID="MONDO:0007522" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39019" SubmissionDate="2018-04-05" DateLastUpdated="2018-04-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120190.0001_EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2" title="COL5A2, 7-BP DEL_EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2" />
        <ClinVarAccession Accession="SCV000039019" DateUpdated="2018-04-09" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Michalickova et al. (1998) screened 28 unrelated individuals and families with typical classic Ehlers-Danlos syndrome for mutations in type V collagen. Of 26 patients in whom no mutations were identified in the COL5A1 gene, they identified abnormalities of COL5A2 cDNA in 2 patients (EDSCL2; 130010). In 1 proband (patient EDS3), the mutation was a 54-bp deletion in heterozygous state (nucleotides 1924-1977 of COL5A2 cDNA). The deletion removed 18 amino acids, gly430 to pro447, from the triple helical domain of the alpha-2(V) chain. The region corresponded to a 54-bp exon, tentatively considered exon 27. This was thought to be due to deletion of the splice acceptor site as a result of a 7-bp deletion that included the consensus ag dinucleotide of the 3-prime splice site of intron 26 and the most 5-prime nucleotides of exon 27.</Attribute>
              <Citation>
                <ID Source="PubMed">9425231</ID>
              </Citation>
              <XRef DB="OMIM" ID="130010" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL5A2" />
          </GeneList>
          <Name>COL5A2, 7-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">7-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120190.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39019" TraitType="Disease" MappingType="Name" MappingValue="EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2" MappingRef="Preferred">
        <MedGen CUI="C0268336" Name="Ehlers-Danlos syndrome, classic type, 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>